(Q42811018)

English

Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 November 2017

Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab (English)

1 reference

Europe PubMed Central

7 November 2017

0 references

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

author name string

Takashi Sonoki

1

1 reference

Europe PubMed Central

7 November 2017

Yaqiong Li

2

1 reference

Europe PubMed Central

7 November 2017

Setsuko Miyanishi

3

1 reference

Europe PubMed Central

7 November 2017

Hirokazu Nakamine

4

1 reference

Europe PubMed Central

7 November 2017

Nobuyoshi Hanaoka

5

1 reference

Europe PubMed Central

7 November 2017

Hiroshi Matsuoka

6

1 reference

Europe PubMed Central

7 November 2017

Ichiro Mori

7

1 reference

Europe PubMed Central

7 November 2017

Hideki Nakakuma

8

1 reference

Europe PubMed Central

7 November 2017

publication date

31 March 2009

1 reference

Europe PubMed Central

7 November 2017

International Journal of Hematology

1 reference

Europe PubMed Central

7 November 2017

89

1 reference

Europe PubMed Central

7 November 2017

400-402

1 reference

Europe PubMed Central

7 November 2017

3

1 reference

Europe PubMed Central

7 November 2017

describes a project that uses

0 references

https://scigraph.springernature.com/pub.10.1007/s12185-009-0295-4

0 references

Epigenetic regulation of CD20 protein expression in a novel B-cell lymphoma cell line, RRBL1, established from a patient treated repeatedly with rituximab-containing chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD20-negative relapse in B-cell lymphoma after treatment with Rituximab.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-009-0295-4

1 reference

Europe PubMed Central

7 November 2017

1 reference

Europe PubMed Central

7 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42811018&oldid=1970919570"